Red drop LAB. is a Swiss biotechnology startup that transforms menstrual blood into an innovative, non-invasive diagnostic tool to advance women's health, providing at-home testing and personalized insights through AI and genomic analysis.
Red drop LAB. is a Swiss biotechnology research company founded in 2024 that specializes in women's health innovation. The startup develops non-invasive diagnostic tools that utilize menstrual blood as a biological resource for health monitoring. By analyzing this fluid, the company aims to identify pathogens and other health indicators, providing insights that have historically been overlooked in medical research. Their solution integrates at-home test kits with a digital application, allowing users to collect samples, access diagnostic results, and receive personalized health recommendations without requiring professional medical assistance.
The company's technology is designed to address systemic gaps in healthcare, such as historical medical biases and the underfunding of women's health research. By transforming menstrual blood into a reliable biomarker, Red drop LAB. seeks to provide healthcare professionals with better tools for early detection and personalized treatment. The platform serves to empower women with information, reduce geographical or financial barriers to care, and shift the societal narrative surrounding menstruation from stigma to health awareness. The organization is headquartered in Aubonne, Switzerland, and focuses on applying genomic analysis and artificial intelligence to interpret complex biological data for improved clinical outcomes.